Literature DB >> 35862012

Variation in Left Ventricular Assist Device Postdischarge Caregiver Requirements: Results From a Mixed-Methods Study With Equity Implications.

Christopher E Knoepke1,2, Bonnie Siry-Bove3, Caitlin Mayton4, Abigail Latimer5, Jan Hart6, Larry A Allen1,2, Stacie L Daugherty1,2,7, Colleen K McIlvennan1, Daniel D Matlock8, Prateeti Khazanie1.   

Abstract

BACKGROUND: Left ventricular assist device (LVAD) evaluation includes a psychosocial assessment, conducted by social workers (SWs) on the advanced heart failure multidisciplinary team. Postdischarge caregiving plans are central to psychosocial evaluation. Caregiving's relationship with LVAD outcomes is mixed, and testing patients' social resources may disadvantage those from historically undertreated groups. We describe variation in policies defining adequate caregiving plans post-LVAD implant and possible impacts on patients from marginalized groups.
METHODS: This was a 2-phase sequential mixed-methods study: (1) phase 1, survey of US-based LVAD SWs, describing assessment structure and policies guiding candidacy outcomes; and (2) phase 2, individual interviews with SWs to further describe how caregiving plan adequacy impacts LVAD candidacy.
RESULTS: Sixty-seven SWs returned surveys (rr=47%) from unique programs. Caregiving plan inadequacy (n=30) was the most common psychosocial dealbreaker. When asked what duration of caregiving is required, 23% indicated ≥3 months, 27% 4 to 12 weeks, and 30% <4 weeks. Two reported no duration requirement, 6 stated an indefinite 24/7 commitment was necessary. Across 22 interviews, SWs mirrored that caregiving plans were the most common psychosocial contraindication. How caregiving is operationalized varied. Participants voiced a tension between extended caregiving improving outcomes and the sense that some people of color, women, or low socioeconomic status patients struggle to meet stringent requirements.
CONCLUSIONS: Policies regarding adequate duration of 24/7 caregiving vary, but inadequate caregiving plans are the most common psychosocial contraindication. Participants worry about patients' ability to meet restrictive requirements, particularly from historically undertreated groups. This highlights a need to operationalize quality caregiving, standardize assessment, and support medically appropriate patients with strained social resources.

Entities:  

Keywords:  caregivers; contraindications; health equity; heart failure; social workers

Mesh:

Year:  2022        PMID: 35862012      PMCID: PMC9388601          DOI: 10.1161/CIRCHEARTFAILURE.122.009583

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   10.447


  22 in total

Review 1.  Quality of life and left ventricular assist device support.

Authors:  Jane Maciver; Heather J Ross
Journal:  Circulation       Date:  2012-08-14       Impact factor: 29.690

2.  The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Fabienne Dobbels; Kathleen L Grady; Sheila G Jowsey-Gregoire; Annemarie Kaan; Kay Kendall; Quincy-Robyn Young; Susan E Abbey; Zeeshan Butt; Catherine C Crone; Sabina De Geest; Christina T Doligalski; Christiane Kugler; Laurie McDonald; Linda Ohler; Liz Painter; Michael G Petty; Desiree Robson; Thomas Schlöglhofer; Terry D Schneekloth; Jonathan P Singer; Patrick J Smith; Heike Spaderna; Jeffrey J Teuteberg; Roger D Yusen; Paula C Zimbrean
Journal:  Psychosomatics       Date:  2018-07-10       Impact factor: 2.386

3.  Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events.

Authors:  Courtenay R Bruce; Charles G Minard; L A Wilhelms; Mackenzie Abraham; Javier Amione-Guerra; Linda Pham; Sherry D Grogan; Barry Trachtenberg; Martin L Smith; Brian A Bruckner; Jerry D Estep; Kristin M Kostick
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-01

4.  Family Caregiving for Individuals With Heart Failure: A Scientific Statement From the American Heart Association.

Authors:  Lisa Kitko; Colleen K McIlvennan; Julie T Bidwell; J Nicholas Dionne-Odom; Shannon M Dunlay; Lisa M Lewis; Ginny Meadows; Elisabeth L P Sattler; Richard Schulz; Anna Strömberg
Journal:  Circulation       Date:  2020-04-30       Impact factor: 29.690

Review 5.  Clinical outcomes after continuous-flow left ventricular assist device: a systematic review.

Authors:  Colleen K McIlvennan; Kate H Magid; Amrut V Ambardekar; Jocelyn S Thompson; Daniel D Matlock; Larry A Allen
Journal:  Circ Heart Fail       Date:  2014-10-07       Impact factor: 8.790

6.  Association of Gender and Race With Allocation of Advanced Heart Failure Therapies.

Authors:  Khadijah Breathett; Erika Yee; Natalie Pool; Megan Hebdon; Janice D Crist; Ryan H Yee; Shannon M Knapp; Sade Solola; Luis Luy; Kathryn Herrera-Theut; Leanne Zabala; Jeff Stone; Marylyn M McEwen; Elizabeth Calhoun; Nancy K Sweitzer
Journal:  JAMA Netw Open       Date:  2020-07-01

7.  Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot".

Authors:  Colleen K McIlvennan; Larry A Allen; Carolyn Nowels; Andreas Brieke; Joseph C Cleveland; Daniel D Matlock
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05-13

Review 8.  Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association.

Authors:  Keith Churchwell; Mitchell S V Elkind; Regina M Benjamin; April P Carson; Edward K Chang; Willie Lawrence; Andrew Mills; Tanya M Odom; Carlos J Rodriguez; Fatima Rodriguez; Eduardo Sanchez; Anjail Z Sharrief; Mario Sims; Olajide Williams
Journal:  Circulation       Date:  2020-11-10       Impact factor: 29.690

9.  Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device.

Authors:  Kelsey Flint; Erin L Chaussee; Kamal Henderson; Khadijah Breathett; Prateeti Khazanie; Jocelyn S Thompson; Colleen K Mcilvennan; Shane J Larue; Daniel D Matlock; Larry A Allen
Journal:  J Card Fail       Date:  2020-12-18       Impact factor: 5.712

10.  Living with a left ventricular assist device: psychological burden and coping: protocol for a cross-sectional and longitudinal qualitative study.

Authors:  Michael Levelink; Harald Christian Eichstaedt; Sven Meyer; Anna Levke Brütt
Journal:  BMJ Open       Date:  2020-10-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.